miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1

Alessandro Matarese1,2, Jessica Gambardella1,3, Angela Lombardi1,4

  • 1Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York, NY 10461, USA.

Cells
|July 10, 2020
PubMed

Insights

MicroRNAs regulate insulin release by targeting beta-arrestin 1, a key player in the glucagon-like peptide-1 receptor pathway. This finding impacts type 2 diabetes treatment strategies.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Glucagon-like peptide-1 (GLP-1) enhances insulin secretion via its receptor on pancreatic beta cells.
  • Beta-arrestin 1 (βARR1) desensitizes the GLP-1 receptor, influencing insulin release.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in regulating beta cell function and insulin secretion.

Purpose of the Study:

  • To investigate the role of specific miRNAs in modulating the GLP-1/βARR1 signaling axis in beta cells.
  • To identify and validate miRNAs that target βARR1 and influence GLP-1-mediated insulin release.

Main Methods:

  • Bioinformatic analysis to predict miRNAs targeting βARR1.
  • Validation of the interaction between identified miRNA (hsa-miR-7-5p, miR-7) and βARR1.
  • Experimental verification of GLP-1's regulation on miR-7 and βARR1 transcription.
  • Assessment of miR-7's impact on GLP-1-induced insulin release and cyclic AMP (cAMP) production in beta cells.

Main Results:

  • Hsa-miR-7-5p (miR-7) was identified as a miRNA targeting βARR1.
  • GLP-1 was confirmed to regulate the transcription of both miR-7 and βARR1.
  • miR-7 significantly modulated GLP-1-induced insulin secretion and cAMP production in beta cells.
  • A direct functional role for miR-7 in targeting βARR1 and regulating GLP-1-mediated insulin release was established.

Conclusions:

  • miR-7 plays a crucial role in regulating GLP-1-mediated insulin release by targeting βARR1 in pancreatic beta cells.
  • This discovery provides novel insights into the molecular mechanisms governing insulin secretion.
  • The findings have significant clinical implications for the development of therapeutic strategies for type 2 diabetes mellitus targeting GLP-1 signaling.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
713
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.0K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.1K